Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Non-cash Items (2024 - 2025)

Anaptysbio (ANAB) has disclosed Non-cash Items for 2 consecutive years, with $180.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 33689.14% year-over-year to $180.4 million, compared with a TTM value of $180.4 million through Dec 2025, up 33689.14%, and an annual FY2025 reading of $180.4 million, up 33689.14% over the prior year.
  • Non-cash Items was $180.4 million for Q4 2025 at Anaptysbio, up from $534000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $180.4 million in Q4 2025 and bottomed at $534000.0 in Q4 2024.